Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07032545 · ClinicalTrials.gov registry record · NA
Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
A NA study of Obesity and Overweight and Breast Cancer Survivorship, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT07032545 is a NA study of Obesity and Overweight and Breast Cancer Survivorship that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 24 participants, below the 465-participant average among 27 other Obesity and Overweight trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07032545, a NA study of Obesity and Overweight and Breast Cancer Survivorship, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
Obesity can pose significant challenges to maintaining long-term health in cancer survivors by increasing their risk of cancer coming back. Eating a healthy diet is an important way to help manage weight and improve overall health. Broccoli microgreens (BMG) are young broccoli plants packed with nutrients, and research suggests they may help prevent cancer. Previous studies in mice showed that BMG can improve gut health and metabolism, leading to better health outcomes in obese animals. This study will test whether BMG can be a useful addition to the diet of obese breast cancer (BC) survivors who have a higher risk of their cancer returning. 24 obese BC survivors will be invited to eat one serving (one cup, \~57 gram) of fresh BMG every day for two weeks. This will help understand if people can stick to this diet, how their bodies respond, and whether it affects metabolism and inflammation-two key factors linked to cancer risk. Biological markers such as body fat, glucose and lipids as well as gut bacterial changes will be analyzed to see how BMG affects individual health. This study may help create new diet strategies to improve health, reduce cancer risk, and support long-term recovery in cancer patients who are overweight or obese. In the future, this research could help doctors personalize nutrition plans to better support cancer survivors.
Conditions Studied
Interventions
- OTHER Broccoli microgreen (BMG)
Study Locations (1)
Maryland
- Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-12-03 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07032545
The ClinicalTrials.gov registry entry for NCT07032545 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 465-participant average among 27 other Obesity and Overweight trials with a reported enrollment target (95% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obesity and Overweight appearing as the primary indexed condition, and to 1 intervention - of which Broccoli microgreen (BMG) is the first listed.
NCT07032545 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT07032545 about?
NCT07032545 is a clinical study titled "Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors". Obesity can pose significant challenges to maintaining long-term health in cancer survivors by increasing their risk of cancer coming back. Eating a healthy diet is an important way to help manage weight and improve overall health. Broccoli microgreens (BMG) are young broccoli plants packed with nut...
What is the current status of trial NCT07032545?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-12-03. Estimated completion is 2028-12-31.
What conditions does trial NCT07032545 study?
This clinical trial studies the following conditions: Obesity and Overweight, Breast Cancer Survivorship.
What interventions are being tested in trial NCT07032545?
The interventions under investigation include: Broccoli microgreen (BMG) (OTHER).
Who is sponsoring clinical trial NCT07032545?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07032545 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity and Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
New Mechanisms of Obesity
RECRUITING · NA
-
Weight Management Intervention in College: A Pilot
RECRUITING · NA
-
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
RECRUITING · NA
-
Muscle and Movement With Anti-Obesity Medications
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.